Study S000020

OBESIAL: A Prospective Interventional Real-world Study of a Multidisciplinary Obesity Management Programme

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record Study Protocol and Statistical Analysis Plan (PDF)

Registration

Registration: NCT07779343
Acronym: OBESIAL
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Masking: NONE
Status: RECRUITING
Enrollment: 300
Start: 2026-01-22
Primary completion: 2028-01-23
Lead sponsor: University of Health Sciences, Algeria
Conditions: Obesity Difficult Airway Airway Management; Obesity Adult Onset; Obesity and Cardiovascular Risk; Obesity Type 2 Diabetes Mellitus
Interventions: DRUG:Semaglutide (Wegovy) weekly injection; BEHAVIORAL:Behavioral Treatment; OTHER:Weight loss
Results posted: FALSE
Individual participant data sharing: UNDECIDED
Secondary identifiers: OTHER:MCHA-MED-2026/01

Registered primary outcomes

Percentage of Participants Achieving ≥5% Weight Loss at Month 18 [18 months follow-up]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.